ClinicalTrials.Veeva

Menu

Usefulness of Calprotectin for Colon Adenoma Screening

K

Konkuk University Medical Center

Status

Unknown

Conditions

Colon Adenoma

Study type

Observational

Funder types

Other

Identifiers

NCT01719198
KUH1220

Details and patient eligibility

About

The fecal calprotectin assay is used widely for inflammatory bowel disease diagnosis and the assessment of the disease activity. Some adenoma patients have elevated fecal calprotectin level, which could mean the role of fecal calprotectin as a screening marker for colon adenoma. We will investigate the usefulness of fecal calprotectin as colon adenoma marker for screening in this study.

Enrollment

500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • over 18 years old adult population

Exclusion criteria

  • none

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems